ImmunityBio, Inc. IBRX
6.75 USD -0.37 (-5.13%)
At closeNov 10, 2026, 7:58 PM EST
6.75 +0.01 +0.08%
After hours · Nov 10, 7:58 PM ET
6.61 Day range 7.27
1.95 52-week range 12.43
- YTD
- +240.66%
- 1 year
- +212.27%
IBRX revenue history
Revenue is income from the company’s ordinary business activities.
113,288,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 113,288,000 | 98,543,000 | 668.31% |
| FY 2024 | 2024-12-31 | 14,745,000 | 14,123,000 | 2270.58% |
| FY 2023 | 2023-12-31 | 622,000 | 382,000 | 159.17% |
| FY 2022 | 2022-12-31 | 240,000 | -694,000 | -74.30% |
| FY 2021 | 2021-12-31 | 934,000 | 329,000 | 54.38% |
| FY 2020 | 2020-12-31 | 605,000 | -1,597,000 | -72.52% |
| FY 2019 | 2019-12-31 | 2,202,000 | 2,155,000 | 4585.11% |
| FY 2018 | 2018-12-31 | 47,000 | 2,000 | 4.44% |
| FY 2017 | 2017-12-31 | 45,000 | 1,000 | 2.27% |
| FY 2016 | 2016-12-31 | 44,000 | -192,000 | -81.36% |
| FY 2015 | 2015-12-31 | 236,000 | -405,000 | -63.18% |
| FY 2014 | 2014-12-31 | 641,000 | 41,000 | 6.83% |
| FY 2013 | 2013-12-31 | 600,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:12.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.